#161933

SK-CO-1 Cell Line

Cat. #161933

SK-CO-1 Cell Line

Cat. #: 161933

Availability: 8-10 weeks

Tissue: Large intestine; Colon

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Lloyd J. Old, Germain Trempe

Institute: Memorial Sloan-Kettering Cancer Center (MSK)

Primary Citation: Fogh et al. 1977. Journal of the National Cancer Institute. PMID: 833871.

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: SK-CO-1 Cell Line
  • Cancer: Digestive / Gastrointestinal cancer
  • Tissue: Large intestine; Colon
  • Donor: This cell line was established in 1972 from a metastatic site (ascites) in a 65-year-old Caucasian male with colorectal adenocarcinoma.
  • Morphology: Epithelial
  • Growth properties: Adherent
  • Products or characteristics of interest: Karyotype: (P7) hypertriploid to hypotetraploid with abnormalities including dicentrics, minutes, rings, secondary constrictions, and 8 large submetacentric markers. Isoenzymes: AK-1, 1-2 ES-D, 1 G6PD, B GLO-I, 1-2 Me-2, 1 PGM1, 1 PGM3, 1-2
  • Description: SK-CO-1 is a human colorectal adenocarcinoma cell line that displays epithelial morphology and grows in adherent tissue culture.
  • Application: 3D cell culture
  • Biosafety level: 1

Target Details

  • Target: Antigen expression: Blood Type O; Rh+; HLA A1, A3, B7, B13

Applications

  • Application: 3D cell culture

Handling

  • Growth medium: McCoy's 5a Medium Modified with fetal bovine serum to a final concentration of 10%.
  • Temperature: 37° C
  • Atmosphere: 5% CO2 in air
  • Shipping conditions: Dry Ice
  • Storage medium: Complete growth medium supplemented with 5% DMSO
  • Str profiling: Amelogenin: X,YCSF1PO: 13D13S317: 14D16S539: 13D5S818: 9,11D7S820: 8,10TH01: 8,9TPOX: 8,11vWA: 18,19D3S1358: 17,18D21S11: 28,30D18S51: 19Penta_E: 13,16Penta_D: 11D8S1179: 12,14FGA: 20,25D19S433: 12,13D2S1338: 17,21

References

  • Trainer et al. 1988. International journal of cancer. 41(2):287-296. PMID: 3338874.